4-Methoxy-phenylmercaptoacetylchlorid | 30893-62-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 4-Methoxy-phenylmercaptoacetylchlorid
• 英文别名: 2-(4-Methoxyphenyl)sulfanylacetyl chloride
• CAS: 30893-62-0
• 化学式: C₉H₉ClO₂S
• 分子量: 216.688
• InChiKey: VMMBQEPTDCVLEL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  51.6
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4-Methoxy-phenylmercaptoacetylchlorid 在 N-乙基哌啶 、 4-二甲氨基吡啶 、 tin(II) trifluoromethanesulfonate 、 N,N'-二环己基碳二亚胺 作用下， 以 二氯甲烷 为溶剂， 反应 2.0h， 生成 3-(2-(1-methyl-5-oxo-2-pyrrolidinyl)((4-methoxyphenyl)thio)acetyl)-4(S)-isopropyl-1,3-thiazolidine-2-thione
  参考文献：
  名称：

  手性锡（II）的非对映选择性烷基化将烯丙基化成环状酰基亚胺离子。（-）-supinidine的不对称全合成

  摘要：

  研究了手性锡（II）烯醇锡（II）10与环酰基亚胺离子5的不对称烷基化反应的范围和机理。还实现了该反应在不对称合成（-）-亚氨嘧啶中的应用。

  DOI：

  10.1016/s0040-4020(01)96008-9
• 作为产物：
  描述：

  2-(4-甲氧基苯基)硫基乙酸酯 在 氯化亚砜 、 N,N-二甲基甲酰胺 作用下， 生成 4-Methoxy-phenylmercaptoacetylchlorid
  参考文献：
  名称：

  Ruechardt,C.; Boeck,H., Chemische Berichte, 1971, vol. 104, p. 577 - 592

  摘要：

  DOI：

文献信息

• CHIRAL SPIRO PHOSPHORUS-NIROGEN-SULPHUR TRIDENTATE LIGAND, PREPARATION METHOD AND APPLICATION THEREOF
  申请人：Zhejiang Jiuzhou Pharmaceutical Co., Ltd.

  公开号：US20180141966A1

  公开（公告）日：2018-05-24

  The present invention relates to a chiral spiro phosphine-nitrogen-sulfur (P—N—S) tridentate ligand, preparation method and application thereof. The P—N—S tridentate ligand is a compound represented by Formula I or Formula II, their racemates, optical isomers, or catalytically acceptable salts thereof. The ligand has a primary structure skeleton characterized as a chiral spiro indan skeleton structure with a thio group. The chiral spiro phosphine-nitrogen-sulfur tridentate ligand can be synthesized by reacting racemic or optical active compound 7-diary/alkyl phosphine-7′-amino-1,1′-spiro-dihydro-indene compound having a spiro-dihydro-indene skeleton as the starting material. The chiral spiro P—N—S tridentate ligand being complex with transition metal salt can be used in an asymmetric catalytic hydrogenation reaction for catalyzing carbonyl compound. In particular, in asymmetric hydrogenation reaction process, being complex with iridium for catalyzing β-alkyl-β-keto ester can obtain a high catalytic activity (a catalyst amount of 0.0002% mol) and high enantioselectivity (up to 99.9% ee) result. So the present invention has a practical value for industrial and commercial production.

  本发明涉及手性螺环膦-氮-硫（P—N—S）三齿配体，其制备方法及应用。P—N—S三齿配体是由化学式I或化学式II代表的化合物，它们的外消旋体、光学异构体或催化可接受的盐。该配体具有主要结构骨架，其特征是具有一个含硫基团的手性螺环茚骨架结构。手性螺环膦-氮-硫三齿配体可以通过将外消旋或光学活性化合物7-二芳基/烷基膦-7'-氨基-1,1'-螺二氢茚化合物作为起始物质来合成，该化合物具有一个螺二氢茚骨架。与过渡金属盐形成络合物的手性螺P—N—S三齿配体可用于不对称催化氢化反应，用于催化羰基化合物。特别地，在不对称氢化反应过程中，与铱形成络合物用于催化β-烷基-β-酮酸酯可以获得高催化活性（0.0002%摩尔的催化剂量）和高对映选择性（高达99.9% ee）的结果。因此，本发明对工业和商业生产具有实际价值。
• PHARMACEUTICAL COMPOSITIONS CONTAINING 2-PYRIDONE DERIVATIVES AS EFFECTIVE COMPONENTS
  申请人：Kato Masatoshi

  公开号：US20090298889A1

  公开（公告）日：2009-12-03

  The present invention herein provides a 2-pyridone derivative which has a cell adhesion-inhibitory activity and which is useful for preventing and/or treating pathema or disease conditions including, for instance, inflammations which relate to leukocytic infiltration. The 2-pyridone derivative is a compound represented by the following general formula (1). In the formula, R 1 represents, for instance, a phenyl or pyridyl group, R 2 represents, for instance, a phenyl group, R 3 represents, for instance, a lower alkyl group, R 4 represents, for instance, a lower alkyl group, R 5 represents, for instance, a lower alkyl group, and R 6 represents, for instance, a lower alkyl group.

  本发明提供了一种2-吡啶酮衍生物，该衍生物具有细胞黏附抑制活性，并可用于预防和/或治疗包括与白细胞浸润有关的炎症在内的病理或疾病状况。2-吡啶酮衍生物是由以下通式（1）表示的化合物。在该式中，R1代表例如苯基或吡啶基，R2代表例如苯基，R3代表例如较低的烷基，R4代表例如较低的烷基，R5代表例如较低的烷基，R6代表例如较低的烷基。
• PHARMACEUTICAL COMPOSITION COMPRISING 2-PYRIDONE DERIVATIVE AS ACTIVE INGREDIENT
  申请人：Sato Pharmaceutical Co. Ltd.

  公开号：EP1897870A1

  公开（公告）日：2008-03-12

  The present invention herein provides a 2-pyridone derivative which has a cell adhesion-inhibitory activity and which is useful for preventing and/or treating pathema or disease conditions including, for instance, inflammations which relate to leukocytic infiltration. The 2-pyridone derivative is a compound represented by the following general formula (1). In the formula, R1 represents, for instance, a phenyl or pyridyl group, R2 represents, for instance, a phenyl group, R3 represents, for instance, a lower alkyl group, R4 represents, for instance, a lower alkyl group, R5 represents, for instance, a lower alkyl group, and R6 represents, for instance, a lower alkyl group:

  本发明提供了一种 2-吡啶酮衍生物，它具有细胞粘附抑制活性，可用于预防和/或治疗病变或疾病，包括例如与白细胞浸润有关的炎症。2 吡啶酮衍生物是由以下通式（1）表示的化合物。式中，R1 代表苯基或吡啶基，R2 代表苯基，R3 代表低级烷基，R4 代表低级烷基，R5 代表低级烷基，R6 代表低级烷基：
• Chiral spiro phosphorus-nirogen-sulphur tridentate ligand, preparation method and application thereof
  申请人：Zhejiang Jiuzhou Pharmaceutical Co., Ltd.

  公开号：US10550138B2

  公开（公告）日：2020-02-04

  The present invention relates to a chiral spiro phosphine-nitrogen-sulfur (P—N—S) tridentate ligand, preparation method and application thereof. The P—N—S tridentate ligand is a compound represented by Formula I or Formula II, their racemates, optical isomers, or catalytically acceptable salts thereof. The ligand has a primary structure skeleton characterized as a chiral spiro indan skeleton structure with a thio group. The chiral spiro phosphine-nitrogen-sulfur tridentate ligand can be synthesized by reacting racemic or optical active compound 7-diary/alkyl phosphine-7′-amino-1, 1′-spiro-dihydro-indene compound having a spiro-dihydro-indene skeleton as the starting material. The chiral spiro P—N—S tridentate ligand being complex with transition metal salt can be used in an asymmetric catalytic hydrogenation reaction for catalyzing carbonyl compound. In particular, in asymmetric hydrogenation reaction process, being complex with iridium for catalyzing β-alkyl-β-keto ester can obtain a high catalytic activity (a catalyst amount of 0.0002% mol) and high enantioselectivity (up to 99.9% ee) result. So the present invention has a practical value for industrial and commercial production.

  本发明涉及一种手性螺膦-氮-硫（P-N-S）三叉配体及其制备方法和应用。P-N-S 三叉配体是由式 I 或式 II 表示的化合物、它们的外消旋体、光学异构体或催化上可接受的盐。配体具有初级结构骨架，其特征为带有硫基的手性螺茚骨架结构。手性螺膦-氮硫三叉配体可以外消旋或光学活性化合物 7-二/烷基膦-7′-氨基-1，1′-螺二氢-茚化合物（具有螺二氢-茚骨架）为起始原料进行反应合成。与过渡金属盐络合的手性螺 P-N-S 三叉配体可用于不对称催化加氢反应，以催化羰基化合物。特别是在不对称氢化反应过程中，与铱络合用于催化 β-烷基-β-酮酯可获得高催化活性（催化剂用量为 0.0002% mol）和高对映选择性（高达 99.9% ee）的结果。因此，本发明具有工业和商业生产的实用价值。
• CHIRAL SPIRO PHOSPHORUS-NITROGEN-SULPHUR TRIDENTATE LIGAND, AND PREPARATION METHOD AND APPLICATION THEREOF
  申请人：Zhejiang Jiuzhou Pharmaceutical Co., Ltd.

  公开号：EP3296302B1

  公开（公告）日：2020-02-12